Replies to post #53486 on Cytodyn Inc (CYDY)

[Evil Rabbit]

I agree. I think the decision to file for BTD at this early juncture was heavily-influenced by communication with the FDA.

[Saltz]

That would normally be my assumption also except Nader has missed in the past so I am not as confident. He is always very optimistic which is effective for inspiring SH’s but ultimately more often than not a let down. I have conditioned my expectations to avoid the disappointment.

IMO the granting of BTD along with BLA submission, acceptance, and approval by the FDA would guarantee a huge run up in SP followed by an uplist.

What excites me is we are fast approaching the fork in the road that will reveal the likely future valuation of Leronlimab.

Will we be used solely for HIV or is this a for real multiple cancer indication platform molecule?

Will we garner $2-$5B for HIV or are we going to blow the gate wide open and add the cancer card?

Many here are 100% convinced that we are going to be the next Humira on steroids. Show me 10 patients with the same outcome along with the same CTC and Tumor results after 24 weeks and I’ll start pissing my pants.